- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT04053504
Feasibility Study of Family Teamwork Peer-Delivery (TEAM)
The purpose of this study is to 1) convene African American and Latino Community Coalitions to adapt Family Teamwork (FT) for school-age youth, and integrate FT with the Smart and Secure Children (SSC) program community-based, peer delivery format, 2) identify facilitators and barriers to parental involvement in diabetes management for African American and Latino parents of children (5-9 years) with T1D to refine, with Community Coalitions the adapted and integrated Family Teamwork- Peer Delivery (FT-P), and 3) evaluate the feasibility, satisfaction, and preliminary outcomes of the FT-P program among African American and Latino parents of school-aged children (5-9 years) withT1D.
A randomized pilot trials will be conducted with African American and Latino families to examine the feasibility, parent satisfaction, and preliminary outcomes of FT-P. Families will be stratified by race/ethnicity, age, and HbA1c strata, and randomized to FT-P plus standard diabetes care or to standard diabetes care alone after completion of baseline assessment using a random numbers table generated by a program created through Baylor College of Medicine's Institute for Clinical Training and Research data management specialists.
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Tipo de estudio
Inscripción (Actual)
Fase
- No aplica
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
Texas
-
Houston, Texas, Estados Unidos, 77030
- Texas Children's Hospital
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
- Primary caregiver of a child ages 5-10 years with type 1 diabetes as defined by the American Diabetes Association criteria
- Having a child with diabetes duration of >1 year
- Self-identified African American or Latino race/ethnicity
- Fluent in English
- Not planning to leave the geographic area during the study
Exclusion Criterion:
• Not fluent in English
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Tratamiento
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
---|---|
Experimental: Intervention
Behavioral intervention delivered by parent peer leaders.
|
Children with T1D and their parent will participate in 6 in-person FT-P group sessions during a 12-month period.
Parents will also participate in monthly telephone support calls with a Parent Leader during the 12-month intervention period.
|
Sin intervención: Standard Care
Standard diabetes care
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
---|---|---|
Intervention Acceptability: Treatment Evaluation Inventory
Periodo de tiempo: Immediately post-intervention
|
Treatment Evaluation Inventory
|
Immediately post-intervention
|
Study Enrollment Rate
Periodo de tiempo: Pre-Randomization
|
Enrollment rate calculated from data obtained from recruitment logs
|
Pre-Randomization
|
Study Attrition Rate
Periodo de tiempo: 12 months
|
Study attrition will be calculated from study logs
|
12 months
|
Monthly Intervention Calls Completed by Parent Leaders
Periodo de tiempo: 12 months
|
Percentage of monthly intervention calls completed by Parent Leaders will be determined from study logs
|
12 months
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
---|---|---|
Change in Rate of Average Blood Glucose
Periodo de tiempo: Change from baseline at 12 months
|
Hemoglobin A1C from medical record
|
Change from baseline at 12 months
|
Change in Frequency of Adherence
Periodo de tiempo: Change from baseline at 12 months
|
Frequency of blood glucose monitoring obtained from blood glucose meter and the Diabetes Self-Management Questionnaire
|
Change from baseline at 12 months
|
Change in Level of Child Diabetes Quality of Life: Pediatric Quality of Life Diabetes Module
Periodo de tiempo: Change from baseline at 12 months
|
Pediatric Quality of Life Total Cumulative Scale (scores range from 0-132 with higher scores indicating worse quality of life)
|
Change from baseline at 12 months
|
Change in Level of Parent involvement in diabetes management tasks
Periodo de tiempo: Change from baseline at 12 months
|
The Diabetes Family Responsibility Questionnaire (scores range from 17-51 with lower scores indicating parent in primarily responsible for diabetes management)
|
Change from baseline at 12 months
|
Change in Level of Parent self-efficacy
Periodo de tiempo: Change from baseline at 12 months
|
Parental Self-Efficacy for Diabetes Management questionnaire scores range from 8-40 with higher scores indicating higher self-efficacy)
|
Change from baseline at 12 months
|
Change in Level of Parent diabetes emotional burden
Periodo de tiempo: Change from baseline at 12 months
|
Problem Areas in Diabetes Revised for Parents (scores range from 0-72 with higher scores indicating less emotional burden)
|
Change from baseline at 12 months
|
Change in Level of Parent Depressive Symptoms
Periodo de tiempo: Change from baseline at 12 months
|
The Center for Epidemiological Depression Studies-Depression scale (scores range from 12-48 with higher scores indicating more depressive symptoms)
|
Change from baseline at 12 months
|
Change in Level of Parent Social Support
Periodo de tiempo: Change from baseline at 12 months
|
2-way Social Support Scale total score (scores range from 0-100 with higher scores indicating more giving and receiving of social support)
|
Change from baseline at 12 months
|
Change in Degree of Impact of diabetes on the family system
Periodo de tiempo: Change from baseline at 12 months
|
Diabetes Family Impact Scale (scores range from 0-56 with higher scores indicating greater impact of diabetes on the family)
|
Change from baseline at 12 months
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Ashley M Butler, PhD, Baylor College of Medicine
Publicaciones y enlaces útiles
Enlaces Útiles
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Actual)
Finalización del estudio (Actual)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- H-40380
- DP3DK113236 (Subvención/contrato del NIH de EE. UU.)
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .
Ensayos clínicos sobre Diabetes tipo 1
-
Oxford Brookes UniversityUniversity of OxfordTerminadoActividad física | Salud Mental Bienestar 1 | Función Cognitiva 1, Social | Academic Attainment | Fitness TestingReino Unido
-
Merck Sharp & Dohme LLCReclutamientoCáncer de pulmón de células no pequeñas | Tumores sólidos | Muerte celular programada-1 (PD1, PD-1) | Ligando 1 de muerte celular programada 1 (PDL1, PD-L1) | Ligando 2 de muerte celular programada 1 (PDL2, PD-L2)Japón
-
Rambam Health Care CampusIsrael Science FoundationTerminado
-
Alvotech Swiss AGTerminado
-
PfizerTerminado
-
SanionaTerminado
-
Calliditas Therapeutics ABEurofins Optimed; York Bioanalytical SolutionTerminado
-
Calliditas Therapeutics ABTerminado
-
JKT Biopharma Co., Ltd.Reclutamiento
-
Graviton Bioscience CorporationTerminado
Ensayos clínicos sobre Family Teamwork-Peer Delivery
-
Washington State UniversityNational Institute of Mental Health (NIMH)ReclutamientoMiembros de la familiaEstados Unidos